Campbell Alliance launches market research and analytics group

Wednesday, March 21, 2012 11:42 AM

Campbell Alliance, an inVentiv Health company and management consulting firm, has launched Encuity Research, the firm's market research and analytics subsidiary.

The launch of Encuity Research immediately follows the acquisition of SDI Health's promotional and medical audit businesses from IMS Health, which closed March 20, 2012. Financial terms of the transaction were not disclosed.

“The audit businesses acquired from IMS will be combined with our existing market research and analytics service lines to create a very robust business that will drive accelerated growth for us in the market research segment,” said Nader Naeymi-Rad, CEO, Campbell Alliance.

Encuity Research, to be based in Newton, Penn., will provide a range of services to the pharmaceutical and biotech industry in five specific areas, including: custom quantitative research and analytics; qualitative research; key opinion leader identification and mapping; and message tracking, including Rapid Recall (SM) message effectiveness studies; syndicated audits, including the Metropolitan Area Promotional Audit, which tracks promotional activity across 15 specialty therapeutic areas; and a wide range of SDI Health medical and promotional audits acquired from IMS Health.

Michael Turner, a six-year veteran with Campbell Alliance, will serve as general manager of Encuity Research. Turner formerly served as vice president of brand management at Campbell Alliance, and before that in consulting and leadership positions at Cognizant and ZS Associates.

Share:          
CWWeekly

January 19

Roche takes $1B majority stake in Foundation Medicine to use genomic testing to personalize oncology treatments

BRANY launches software, iPad app to streamline protocol creation for investigator-initiated trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs